BackPear Therapeutics- Warrants (01/12/2026) Overview

Pear Therapeutics- Warrants (01/12/2026) Long Term Debt

Pear Therapeutics- Warrants (01/12/2026)'s long-term debt is $8.2M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$8.18M

Peer trimmed avg / median

Loading

Pear Therapeutics- Warrants (01/12/2026) Long Term Debt History

Loading

Pear Therapeutics- Warrants (01/12/2026) vs. peers: Long Term Debt Comparison

Loading

Pear Therapeutics- Warrants (01/12/2026) Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pear Therapeutics- Warrants (01/12/2026) (PEARW) FAQ

As of the most recent data (December 2022), PEARW shows a long-term debt of $8.2M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEARW's long-term debt is now $8.2M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics- Warrants (01/12/2026) is outperforming or lagging.

Tracking PEARW's long-term debt over time shows whether Pear Therapeutics- Warrants (01/12/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $8.2M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Pear Therapeutics- Warrants (01/12/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $8.2M) with ownership activity and broader fundamentals.